Cross‐linking of the CAMPATH‐1 antigen (CD52) mediates growth inhibition in human B‐ and T‐lymphoma cell lines, and subsequent emergence of CD52‐deficient cells-Reference-Cited by-同舟云学术

Cross‐linking of the CAMPATH‐1 antigen (CD52) mediates growth inhibition in human B‐ and T‐lymphoma cell lines, and subsequent emergence of CD52‐deficient cells

Published:1998-11 Issue:3 Volume:95 Page:427-436
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:Immunology

Author:

ROWAN ¹,TITE ¹,TOPLEY ¹,BRETT ¹

Affiliation:

1. Immunology Unit, Glaxo‐Wellcome Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, UK

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2567.1998.00615.x

Reference34 articles.

1. The CAMPATH-1 antigen (CDw52)

2. Characterization of the CAMPATH-1 (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone

3. Structure of the CAMPATH‐1H antigen a glycosylphosphatidylinositol‐anchored glycoprotein which is an exceptionally good target for complement lysis.;Xia M‐Q.;Biochem J,1993

4. Effects of CAMPATH‐1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype.;Dyer M.J.S.;Blood,1988

5. IMPORTANCE OF ANTIGEN SPECIFICITY FOR COMPLEMENT-MEDIATED LYSIS BY MONOCLONAL ANTIBODIES

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cis-interaction between CD52 and T cell receptor complex interferes with CD4+ T cell activation in acute decompensation of cirrhosis;eBioMedicine;2024-10

2. Induction Therapy;Transplantation of the Pancreas;2023

3. Frequency of Paroxysmal Nocturnal Hemoglobinuria in Patients with Lymphoma;Middle Black Sea Journal of Health Science;2022-01-25

4. Novel targeted therapies of T cell lymphomas;Journal of Hematology & Oncology;2020-12

5. Detecting and predicting neutralization of alemtuzumab responses in MS;Neurology - Neuroimmunology Neuroinflammation;2020-06-04